TXN and metabolic disease: Oxidative stress is considered to be a possible elicitor in the development and disease activity of RA35 and other diseases, such as metabolic disorder.36 One possibility for the organisms to counteract high levels of oxidative metabolites is to increase the level of the oxidoreductase Trx1.